Increased Lower Limb Spasticity but Not Strength or Function Following a Single-Dose Serotonin Reuptake Inhibitor in Chronic Stroke

Archives of Physical Medicine and Rehabilitation

Volumn 96, Issue 12, 2015, Pages 2112-2119

  Gourab, Krishnaj ^a   Schmit, Brian D ^a,b   Hornby, T George ^b,c  

^a Marquette University   (United States)

^b REHABILITATION INSTITUTE OF CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Muscle spasticity; Muscle strength; Rehabilitation; Serotonin; Stroke

Indexed keywords

ESCITALOPRAM; PLACEBO; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROCNEMIUS MUSCLE; HEMIPARESIS; HUMAN; KNEE FUNCTION; LEG; LOWER LIMB SPASTICITY; MAJOR CLINICAL STUDY; MALE; MYOTATIC REFLEX; OUTPATIENT; PARESIS; PASSIVE MOVEMENT; PHYSICAL MEDICINE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION MEDICINE; SEROTONIN RELEASE; SINGLE DRUG DOSE; SPASTICITY; AGED; ANKLE; CHRONIC DISEASE; CROSSOVER PROCEDURE; HEMIPLEGIA; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE; MIDDLE AGED; MUSCLE SPASTICITY; MUSCLE STRENGTH; PATHOPHYSIOLOGY; STROKE;

AGED; ANKLE; CHRONIC DISEASE; CITALOPRAM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEMIPLEGIA; HUMANS; KNEE; MALE; MIDDLE AGED; MUSCLE SPASTICITY; MUSCLE STRENGTH; RANGE OF MOTION, ARTICULAR; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 84947780071     PISSN: 00039993     EISSN: 1532821X     Source Type: Journal    
DOI: 10.1016/j.apmr.2015.08.431     Document Type: Article

References (53)

1. B. Bobath Adult hemiplegia: evaluation and treatment 3rd ed. 1990 Butterworth-Heinemann Oxford
2. R.T. Katz, and W.Z. Rymer Spastic hypertonia: mechanisms and measurement Arch Phys Med Rehabil 70 1989 144 155
3. S.A. Sahrmann, and B.J. Norton The relationship of voluntary movement to spasticity in the upper motor neuron syndrome Ann Neurol 2 1977 460 465
4. D.G. Kamper, H.C. Fischer, E.G. Cruz, and W.Z. Rymer Weakness is the primary contributor to finger impairment in chronic stroke Arch Phys Med Rehabil 87 2006 1262 1269
5. R. Beer, J. Dewald, and Z. Rymer Disturbances of voluntary movement coordination in stroke: problems of planning or execution? Prog Brain Res 123 1999 455 460
6. R.F. Beer, J.P. Dewald, and W.Z. Rymer Deficits in the coordination of multijoint arm movements in patients with hemiparesis: evidence for disturbed control of limb dynamics Exp Brain Res 131 2000 305 319
7. C.L. Watkins, M.J. Leathley, J.M. Gregson, A.P. Moore, T.L. Smith, and A.K. Sharma Prevalence of spasticity post stroke Clin Rehabil 16 2002 515 522
8. D.K. Sommerfeld, E.U. Eek, A.-K. Svensson, L.W. Holmqvist, and M.H. von Arbin Spasticity after stroke: its occurrence and association with motor impairments and activity limitations Stroke 35 2004 134 139
9. A.-K. Welmer, M. von Arbin, L. Widen Holmqvist, and D.K. Sommerfeld Spasticity and its association with functioning and health-related quality of life 18 months after stroke Cerebrovasc Dis 21 2006 247 253
10. C.T. Leonard, K.A. Gardipee, J.R. Koontz, J.-H. Anderson, and S.A. Wilkins Correlation between impairment and motor performance during reaching tasks in subjects with spastic hemiparesis J Rehabil Med 38 2006 243 249
11. M.A. el-Abd, I.K. Ibrahim, and V. Dietz Impaired activation pattern in antagonistic elbow muscles of patients with spastic hemiparesis: contribution to movement disorder Electromyogr Clin Neurophysiol 33 1993 247 255
12. C. Gowland, H. deBruin, J.V. Basmajian, N. Plews, and I. Burcea Agonist and antagonist activity during voluntary upper-limb movement in patients with stroke Phys Ther 72 1992 624 633
13. R.W. Bohannon, and A.W. Andrews Correlation of knee extensor muscle torque and spasticity with gait speed in patients with stroke Arch Phys Med Rehabil 71 1990 330 333
14. A.B. Ward Spasticity treatment with botulinum toxins J Neural Transm 115 2008 607 616
15. L. Kamen, H.R. Henney III, and J.D. Runyan A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury Curr Med Res Opin 24 2008 425 439
16. E. Montane, A. Vallano, and J.R. Laporte Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review [See comment] Neurology 63 2004 1357 1363
17. J. Pariente, I. Loubinoux, C. Carel, and et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke Ann Neurol 50 2001 718 729
18. F. Chollet, J. Tardy, J.F. Albucher, and et al. Monoaminergic drugs for motor recovery after ischemic stroke Ann Phys Rehabil Med 57 2014 509 519
19. F. Chollet, J. Tardy, J.F. Albucher, and et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial Lancet Neurol 10 2011 123 130
20. S. Zittel, C. Weiller, and J. Liepert Citalopram improves dexterity in chronic stroke patients Neurorehabil Neural Repair 22 2008 311 314
21. B.L. Jacobs, and E.C. Azmitia Structure and function of the brain serotonin system Physiol Rev 72 1992 165 229
22. B.L. Jacobs, and C.A. Fornal Activity of serotonergic neurons in behaving animals Neuropsychopharmacology 21 1999 9S 15S
23. B.L. Jacobs, F.J. Martin-Cora, and C.A. Fornal Activity of medullary serotonergic neurons in freely moving animals Brain Res Brain Res Rev 40 2002 45 52
24. B.J. Schmidt, and L.M. Jordan The role of serotonin in reflex modulation and locomotor rhythm production in the mammalian spinal cord Brain Res Bull 53 2000 689 710
25. B.L. Jacobs, and C.A. Fornal Serotonin and motor activity Curr Opin Neurobiol 7 1997 820 825
26. I. Loubinoux, K. Boulanouar, J.P. Ranjeva, and et al. Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks J Cereb Blood Flow Metab 19 1999 1365 1375
27. A. Gerdelat-Mas, I. Loubinoux, D. Tombari, O. Rascol, F. Chollet, and M. Simonetta-Moreau Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects Neuroimage 27 2005 314 322
28. I. Loubinoux, D. Tombari, J. Pariente, and et al. Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer Neuroimage 27 2005 299 313
29. M. Dam, P. Tonin, A. De Boni, and et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy Stroke 27 1996 1211 1214
30. C.K. Thompson, and T.G. Hornby Divergent modulation of clinical measures of volitional and reflexive motor behaviors following serotonergic medications in human incomplete spinal cord injury J Neurotrauma 30 2013 498 502
31. C.K. Thompson, A. Jayaraman, C. Kinnaird, and T.G. Hornby Methods to quantify pharmacologically induced alterations in motor function in human incomplete SCI J Vis Exp 50 2011 2148
32. E. Jankowska, I. Hammar, B. Chojnicka, and C.H. Hedén Effects of monoamines on interneurons in four spinal reflex pathways from group I and/or group II muscle afferents Eur J Neurosci 12 2000 701
33. M.Y. Wang, and N.J. Dun 5-Hydroxytryptamine responses in neonate rat motoneurones in vitro J Physiol 430 1990 87 103
34. K.A. Stolp-Smith, and M.C. Wainberg Antidepressant exacerbation of spasticity Arch Phys Med Rehabil 80 1999 339 342
35. H.I. Berends, J. Nijlant, M. van Putten, K.L. Movig, and M.J. IJzerman Single dose of fluoxetine increases muscle activation in chronic stroke patients Clin Neuropharmacol 32 2009 1 5
36. J.S. Carp, and W.Z. Rymer Enhancement by serotonin of tonic vibration and stretch reflexes in the decerebrate cat Exp Brain Res 62 1986 111 122
37. S.J. Fung, and C.D. Barnes Raphe-produced excitation of spinal cord motoneurons in the cat Neurosci Lett 103 1989 185 190
38. L. Turner-Stokes, and N. Hassan Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: treatment alternatives Clin Rehabil 16 2002 248 260
39. D.J. Gladstone, C.J. Danells, and S.E. Black The Fugl-Meyer assessment of motor recovery after stroke: a critical review of its measurement properties Neurorehabil Neural Repair 16 2002 232 240
40. B. Ashworth Preliminary trial of carisoprodol in multiple sclerosis Practitioner 192 1964 540 542
41. T.N. Tombaugh Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS Arch Clin Neuropsychol 20 2005 485 503
42. B. Søgaard, H. Mengel, N. Rao, and F. Larsen The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects J Clin Pharmacol 45 2005 1400
43. B.D. Schmit, A. McKenna-Cole, and W.Z. Rymer Flexor reflexes in chronic spinal cord injury triggered by imposed ankle rotation Muscle Nerve 23 2000 793 803
44. T.G. Hornby, J.H. Kahn, M. Wu, and B.D. Schmit Temporal facilitation of spastic stretch reflexes following human spinal cord injury J Physiol 571 2006 593 604
45. S. Barasi, and M.H. Roberts The modification of lumbar motoneurone excitability by stimulation of a putative 5-hydroxytryptamine pathway Br J Pharmacol 52 1974 339 348
46. J.F. Miller, K.D. Paul, R.H. Lee, W.Z. Rymer, and C.J. Heckman Restoration of extensor excitability in the acute spinal cat by the 5-HT2 agonist DOI J Neurophysiol 75 1996 620 628
47. T.G. Hornby, J.C. McDonagh, R.M. Reinking, and D.G. Stuart Effects of excitatory modulation on intrinsic properties of turtle motoneurons J Neurophysiol 88 2002 86 97
48. T.G. Hornby, J.C. McDonagh, R.M. Reinking, and D.G. Stuart Motoneurons: a preferred firing range across vertebrate species? Muscle Nerve 25 2002 632 648
49. S.C. Veasey, C.A. Fornal, C.W. Metzler, and B.L. Jacobs Response of serotonergic caudal raphe neurons in relation to specific motor activities in freely moving cats J Neurosci 15 1995 5346 5359
50. S.C. Veasey, C.A. Fornal, C.W. Metzler, and B.L. Jacobs Single-unit responses of serotonergic dorsal raphe neurons to specific motor challenges in freely moving cats Neuroscience 79 1997 161 169
51. K.A. Leech, C.R. Kinnaird, and T.G. Hornby Effects of serotonergic medications on locomotor performance in humans with incomplete spinal cord injury J Neurotrauma 31 2014 1334 1342
52. A.J. Fong, L.L. Cai, C.K. Otoshi, and et al. Spinal cord-transected mice learn to step in response to quipazine treatment and robotic training J Neurosci 25 2005 11738 11747
53. S.H. Kennedy, H.F. Andersen, and R.W. Lam Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis J Psychiatry Neurosci 31 2006 122 131